Welcome to Panic Disorder Guide
New Treatment For Panic Disorder Article
. For a permanent link to this article, or to bookmark it for further reading, click here.
Living with Anxiety
from: Phil Wiley
Living with Anxiety
by Phil Wiley
Anxiety is a disorder that fills people’s lives with fear and nervousness.
People can have anxiety in a range of forms including panic disorder, obsessive-compulsive disorder, post-traumatic stress disorder, social anxiety disorder (also known as social phobia), phobias and generalized anxiety disorder.
Everyone is familiar with the feeling of anxiety – nervousness, a knot of fear or a sinking feeling in your stomach, the feeling of fight or flight. But imagine having to live with that feeling every day?
Quite often people who have anxiety disorders also suffer from depression and this needs to be treated along with their anxiety disorder. Symptoms of depression include feelings of sadness, hopelessness, changes in appetite or sleep, low energy, and difficulty concentrating.
Environmental, psychological, genetic and bodily factors can all contribute to the risk of a person developing an anxiety disorder. Because of this some people are more at risk than others and some anxiety disorders have more of a relation to genetics than others.
There is a four to seven times increased risk of developing panic disorder for close relatives of those who are already sufferers.
Many people who live with anxiety disorders live their lives suffering and remain untreated. However, anxiety is very treatable with a combination of anxiety-reducing drugs and other therapies.
A specific phobia is an intense fear of something that poses little or no actual danger. Common phobias can include spiders, closed-in places, heights, escalators, tunnels, highway driving, water, flying, dogs, and injuries involving blood.
People with panic disorder have feelings of terror that strike suddenly and repeatedly without warning and are often highly anxious between attacks about where and when the next one will occur.
Social phobia or social anxiety disorder involves overwhelming anxiety and excessive self-consciousness in everyday social situations. Sufferers have a persistent, intense, and chronic fear of being watched and judged by others and being embarrassed or humiliated by their own actions.
Those with obsessive-compulsive disorder suffer from anxious thoughts or rituals they feel they can't control. They can be suffer from persistent, unwelcome thoughts or images, or by the urgent need to engage in certain rituals such as washing their hands a certain number of times or getting dressed following a very strict routine.
Post-traumatic stress disorder can develop following a terrifying event. Those with the disorder have persistent frightening thoughts and memories of their ordeal and feel emotionally numb.
Generalized anxiety disorder goes beyond everyday anxiety. It is a chronic disorder that involves unprovoked exaggerated worry and tension.
Article by health writer Kate Wiley of
href=http://www.healthy-shopper.com
target=_blank>http://www.healthy-shopper.com Health in 1
href=http://www.health-in-1.com
target=_blank>http://www.health-in-1.com
and Advice on Health
target=_blank>http://www.advice-on-health.com
You may use this article on your website providing you include the above
author bio and active link to our health sites.
About the author:
Kate and Phil Wiley run the popular health sites
href=http://www.healthy-shopper.com
target=_blank>http://www.healthy-shopper.com Health in 1
href=http://www.health-in-1.com
target=_blank>http://www.health-in-1.com and Advice on Health
href=http://www.advice-on-health.com
target=_blank>http://www.advice-on-health.com
New Treatment For Panic Disorder News
Anxiety therapy doesn't work as well in elderly: study
NEW YORK (Reuters Health) - A form of talk therapy called cognitive behavioral therapy appears to help older adults battle anxiety disorders slightly better than other approaches, but not as well as in younger adults, according to a new study. "Cognitive behavioral therapy is the mainstay for treating anxiety disorders in younger adults. Its lower effect in older adults in this study is ...
Read more...Edgemont - New Fluoxetine Tablets, 60 mg Now Available
AUSTIN, Texas, Jan. 23, 2012 /PRNewswire/ --Â Edgemont Pharmaceuticals, LLC, a neuroscience focused company, today announced Fluoxetine Tablets 60 mg are now available by prescription nationwide. This is ...
Read more...Cystic Fibrosis - Important New Symptom Relief Information Released by OxygenRemedy.org Today
Important new information for Cystic fibrosis relief is now available from OxygenRemedy.org. Although well established in other countries, controlled breathing exercises are not well known in the Untied States. OxygenRemedy.org is changing that, beginning now, with information needed by Cystic fibrosis suffers that many will find brings a reduction in Cystic fibrosis symptoms in two weeks or ...
Read more...Birmingham Maple Clinic Announces New Report Shows Mental Illness on the Rise in the US
Birmingham Maple Clinic recently reported on the the rise of mental illness in the US, based on the results of last year's SAMHSA study which found that 1 in 5 Americans reported some form of mental illness in the last year.Birmingham, MI (PRWEB) January 26, 2012 The Birmingham Maple Clinic, the premier mental health treatment center in Michigan, recently reported on the results of the Substance ...
Read more...Grant aimed at improving schizophrenia treatment
(SACRAMENTO, Calif.) - Michael Minzenberg, a UC Davis psychiatry researcher, has been awarded a prestigious three-year, $200,000 seed grant from the Dana Foundation to study the brains of patients being treated for schizophrenia
Read more...'Club Drug' Cure?
More data is now available—this time from the Ben Taub General Hospital in Houston, Texas—suggesting that the “club drug” ketamine can rapidly relieve symptoms of major depression.
Read more...Grant will fund study of cognition and schizophrenia
SACRAMENTO — Michael Minzenberg, a UC Davis psychiatry researcher, has been awarded a prestigious three-year, $200,000 seed grant from the Dana Foundation to study the brains of patients being treated for schizophrenia to determine how additional treatment to improve cognition interacts with antipsychotic medication.
Read more...